Acusphere Submits New Drug Application For FDA Approval Of Imagify
   
 
Home | Support
 
Headline News:
FDA
Fake Drugs
Drug Testing
 
 
Acusphere Submits New Drug Application For FDA Approval Of Imagify
5 May 08, 14:08
Acusphere Inc., announced recently the submission of a New Drug Application (NDA) to the U.S. Food & Drug Administration (FDA) for approval to market its lead product candidate, Imagify (Perflubutane Polymer Microspheres for Injectable Suspension)
more

 

 
© 2007 nafdacnigeria.org